Comments
Alembic Pharmaceuticals has received tentative approval of the US Food and Drug Administration for Celecoxib, an anti-inflammatory oral drug, the company said in a statement to the exchanges. The company has received the tentative approval for Celecoxib capsules of the potency of 50 mg, 100 mg, 200 mg and 400 mg. However, shares of the company were down 2.5 per cent at ₹661 on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.